A purple and pink letter v on a white background.
February 1, 2022

Clinical Bulletin: Treat C-section Scars Using Ablation and Resurfacing of the Skin

Approximately one-third of all births in the United States are done using C-sections, and that rate is increasing every year as more women opt for this procedure. The abdominal surgical scar left by a C-section may be accompanied by pain, tenderness, rigidity, and itching. Furthermore, the appearance of the abdominal scar can be of a concern to some women.

Fortunately, there is a non-invasive solution that can produce satisfactory results on C-section scars without the downtime. As discussed by Dr. Kai O Kaye, board certified plastic surgeon and founder of Ocean Clinic in this clinical bulletin, he explores the option   to treat   abdominal   scarring   using the   Venus   Viva™   MD   NanoFractional   Radio  F requency   (RF)   device. He explains in detail the parameters and settings on this highly customizable skin resurfacing solution that were able to produce results like this:

A before and after picture of a woman 's stomach with a scar.

As the radio frequency energy is produced by an electric current rather than a light source, it is not scattered by tissue or absorbed by melanin, making it possible for patients with Fitzpatrick skin types V and VI to benefit from treatment. Dr. Kaye trusts Venus Viva™ MD for its ease of use and the safety efficacy profile of the treatment. He is able to deliver exactly the amount of energy needed for a given scar by selecting voltage and pulse-width independently with the desired combination of ablation and coagulation. Topical numbing cream is typically used to manage any discomfort during treatment.

C-section   scars   are   often   thick   and   with   strong adhesions to the underlying fascia, so the goal is to have an   increased   depth   of   energy   delivered   into   the   tissue   to   maximize ablation. Dr. Kaye generally works with a setpoint of parameters at 260-280 V and a pulse width at 25-28 ms. Depending on   scar   initial   status   and   response,   as   well   as   skin   type,   3-6   treatments   are   typically   necessary   to   achieve   the   desired   change   in   the   C-section   appearance.

Access this bulletin and see how you can leverage the customizability of Venus Viva™ MD to treat this common concern.  

Click the download button below to read Dr. Kaye’s take on maximizing the efficacy of using ablation and resurfacing of the skin to treat C-section scars.

 

By Yoni Nowmalki July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.
May 22, 2026
Skin cancer radiotherapy improves treatment precision and patient outcomes. Learn how dermatology clinics use it in modern care plans.